Milan-based Qura, an AI-powered full-stack health platform, has closed a €1.5 million pre-seed round led by United Ventures, with participation from Vento, Italian Angels for Growth (IAG) and several individual angel investors.

Addressing Gaps in Preventive Care

Qura aims to address the issue of persistent subclinical symptoms, such as chronic fatigue or hormonal imbalances, which are often not adequately managed by traditional healthcare. The platform offers an integrated care pathway: members complete comprehensive blood testing, followed by AI-driven analysis and a 45-minute consultation with a dedicated physician. Each user receives a personalised health plan outlining immediate actions and longer-term monitoring.

A Hybrid and Compliant Model

Qura's model keeps physicians at the center of care, leveraging AI to improve efficiency and personalization. The company is building an EU-native platform that is GDPR-compliant and integrated with local laboratory networks to ensure regulatory compliance.

Expansion and Future Development

The new funding will be used to expand medical, engineering and operations teams, invest in digital marketing and community-led growth, advance Qura’s AI health intelligence capabilities, and prepare for expansion into additional European markets.